Repeat Liquid and Tissue Biopsy Practices in mNSCLC
Nurse Practitioner Lauren Welch and Dr Michelle Shiller explain if and when they would offer repeat liquid or tissue biopsies to a patient with mNSCLC, and discuss how often patients request “serial biopsies” for detecting treatment response and/or disease progression.
Watch
Considerations for First-Line Treatment Selection for Patients with mNSCLC and Brain Metastases
A key opinion leader muses on the treatments she would consider for a patient with mNSCLC, an EGFR exon 20 mutation, and brain metastases.
Watch
Tucatinib, Trastuzumab, and Capecitabine for Leptomeningeal Metastases in Breast Tumors
December 5th 2022Erica Stringer-Reasor, MD, discusses the leptomeningeal metastases in patients with breast cancer and an FDA-approved targeted therapy/chemotherapy combination that is being studied as a treatment.
Watch
First- and Second-Line Treatment Options for Patients with mNSCLC and an EGFR Exon 20 Mutation
The panel reviews the first- and second-line treatment options for the patient in the presented case, before and after knowing her molecular testing results.
Watch
A Pathologist Outlines Typical Tumor Tissue Processing Steps after Biopsy in NSCLC
Michelle Shiller, DO, AP/CP, MGP, describes the process of tissue biopsy testing at her institution from start to finish, and Zosia Piotrowska, MD, explains the likelihood of targetable alterations in cases of mNSCLC in patients with no smoking history.
Watch